Gampong, Anita S.

HRN: 14-00-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/29/2023
09/08/2023
IV
4.5g
Q6
Sepsis; Skin Infection
Waiting Final Action 
08/29/2023
MUPIROCIN 2%, 15G (TUBE)
08/29/2023
09/08/2023
TOPICAL
2%
Q8
Skin Infection
Waiting Final Action 
08/29/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
08/29/2023
09/04/2023
ORAL
100,000iu
Q8
Aphthous Ulcer
Waiting Final Action 
08/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/30/2023
09/09/2023
IV
2.25g
Q6
Sepsis:skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: